Hol dir die App Get the App
⭐️⭐️⭐️⭐️⭐️
44 Bewertungen
Zur App
DAX 26.458,50 0,19% Dow Jones 53.715,50 -0,27% MDAX 32.496,90 0,40% Nikkei 225 68.623,30 -0,68% S&P 500 7.782,88 -0,23% STOXX Europe 50 6.545,00 -0,27% Nasdaq 100 30.026,10 -0,20% Bitcoin 62.978,95 USD 0,23% Gold 140,71 USD 0,02% EUR/USD 1,16 USD 0,33%
DAX 26.458,50 0,19% Dow Jones 53.715,50 -0,27% MDAX 32.496,90 0,40% Nikkei 225 68.623,30 -0,68% S&P 500 7.782,88 -0,23% STOXX Europe 50 6.545,00 -0,27% Nasdaq 100 30.026,10 -0,20% Bitcoin 62.978,95 USD 0,23% Gold 140,71 USD 0,02% EUR/USD 1,16 USD 0,33%
+49 (0) 172 414 333 6
Wertpapiere

Aktie US74834L1008

Quest Diagnostics Incorporated

202,00 €

  • 0,00 €
  • |
  • 0,00 %

Your browser does not support the canvas element.

  • Aug.
  • Okt.
  • Nov.
  • Jan.
  • März
  • Mai
  • Juni
  • Aug.
  • 145
  • 160
  • 180
  • 195
  • 210

ERTRÄGE

Warnung: Die Dividende wurde um 74,6% gekürzt auf 0,68 € pro Aktie. Dies könnte eine strategische Entscheidung sein oder auf veränderte finanzielle Prioritäten hinweisen. Aktionäre sollten prüfen, ob dies ein isolierter Rückschlag oder ein Zeichen struktureller Probleme ist.

0,68 €

Jährliche Dividende

0,34 %

Rendite

  • 0,68 €

    Apr.
  • 0,68 €

    Juli
  • 0,68 €

    Okt.
  • 0,68 €

    Jan.

-74,60 %

Dividenden-Wachstum

  • 17

  • 18

  • 19

  • 20

  • 21

  • 22

  • 23

  • 24

  • 25

  • 26

31,34 %

Ausschüttungsquote

  • A

    31 %
  • 69 %

    G

  • A

    16 %
  • 84 %

    OCF

Historische Dividenden

    • 0,00 %
    • 0,00 €
    2019
    • 1,97 %
    • 1,87 €
    2020
    • 1,61 %
    • 2,05 €
    2021
    • 2,14 %
    • 2,76 €
    2022
    • 1,80 %
    • 2,36 €
    2023
    • 1,88 %
    • 2,50 €
    2024
    • 1,77 %
    • 2,66 €
    2025
    • 0,45 %
    • 0,68 €
    2026

UNTERNEHMEN

10,8 Mrd. $

Umsatz

  • 968,0 Mio.

    NG

  • 0,00

    F&E

  • 3,6 Mrd.

    BG

  • 10,8 Mrd.

    U

9,91 %

Umsatz-Wachstum

  • 22

  • 23

  • 24

  • 25

  • 26

968,0 Mio. $

Nettogewinn

  • 13,5 %

    ROE
  • 8,9 %

    ROS
  • 6,0 %

    ROA
  • 18,4 %

    GPM

1,9 Mrd. $

Operativer Cashflow

  • FCF

    74 %
  • 26 %

    CapEx

7,1 Mrd. $

Eigenkapital

  • EK 45 %
  • 55 % FK

55.000

Mitarbeiter

  • 197.272,7 $

    Umsatz / MA
  • 17.600,0 $

    Gewinn / MA

KGV

21,63 $

KBV

2,96 $

KCV

15,23 $

KUV

1,96 $

EV/EBITDA

14,91 $

EV/EBIT

19,57 $

EV/FCF

21,33 $

EV/Umsatz

2,74 $

EnterpriseValue

29,7 Mrd. $

Eigenkapitalrendite

13,54 %

Umsatzrendite

8,92 %

EBIT-Marge

13,99 %

EBITDA-Marge

18,37 %

Kapitalumschlag

0,68 $

Gesamtkapitalrendite

6,04 %

Eigenkapitalquote

0,45 $

Fremdkapitalquote

0,55 $

Verschuldungsgrad

1,24 $

Dyn. Verschuldungsgrad

4,70 $

Sachinvestitionsquote

-0,26 $

Anlagendeckungsgrad 1

1,93 $

Anlagendeckungsgrad 2

0,98 $

Liquidität 1. Grades

0,19 $

Liquidität 2. Grades

0,91 $

Liquidität 3. Grades

1,17 $

Dividende pro Aktie

2,72 $

Dividendenrendite

1,45 %

Ausschüttungsquote

31,34 %

Buchwert pro Aktie

63,41 $

Cashflow pro Aktie

16,68 $
Stand: 30.09.2025 TTM

Fakten

  • Sitz

    USA

  • Hauptsitz

    Secaucus

  • Börsengang

    17.12.1996

  • Ausstehende Aktien

    113,00 Mio.

  • Mitarbeiter

    55,00 Tsd.

  • Währung

    USD

  • Sektor

    Gesundheitswesen

  • Industrie

    Medical - Diagnostics & Research

  • Börse

    NYSE

  • Ticker

    DGX

  • Webseite

    questdiagnostics.com

Aktie

Unternehmensinfos

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.